propranolol has been researched along with begacestat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubele, DL; Bard, F; Basi, GS; Bova, MP; Bowers, S; Brigham, EF; Dappen, MS; Dressen, D; Garofalo, AW; Goldbach, E; Hemphill, SS; Hom, RK; Hu, K; Jagodzinski, JJ; Keim, PS; Kholodenko, D; Konradi, AW; Kwong, GT; Latimer, LH; Lee, M; Liao, A; Marugg, JL; Mattson, MN; Motter, RN; Neitzel, ML; Ness, DK; Nguyen, L; Peterson, B; Probst, G; Quincy, D; Quinn, KP; Ruslim, L; Sacayon, P; Santiago, P; Sauer, JM; Semko, CM; Sham, HL; Smith, J; Sun, M; Tanaka, K; Tanaka, P; Truong, AP; Wallace, W; Willits, C; Wong, K; Wu, J; Xu, YZ; Ye, XM; Yednock, TA; Zhang, H; Zmolek, W | 1 |
1 other study(ies) available for propranolol and begacestat
| Article | Year |
|---|---|
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Area Under Curve; Basic Helix-Loop-Helix Transcription Factors; Dogs; Dose-Response Relationship, Drug; Drug Design; Drug Stability; Enzyme Inhibitors; Gene Expression; Heterocyclic Compounds, 3-Ring; Homeodomain Proteins; Humans; Male; Mice; Microsomes, Liver; Models, Chemical; Molecular Structure; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Notch; RNA, Messenger; Structure-Activity Relationship; Sulfonamides; Time Factors; Transcription Factor HES-1 | 2013 |